UBS Group »

Aptose Biosciences shares owned by UBS Group

Quarter-by-quarter ownership of Aptose Biosciences (APTO) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Aptose Biosciences

Jul 2023Oct 2023Jan 2024Apr 2024Jul 2024Oct 2024Jan 2025020k40k050k100k
Value ($)Share countHistorical APTO position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Aptose Biosciences held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aptose Biosciences by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $13k 58k 0.23
2024-09-30 $55k 134k 0.41
2023-12-31 $19k 7.6k 2.54
2023-09-30 $8 3 2.67
2023-06-30 $124 27 4.63

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Aptose Biosciences

Bleichroeder
Sigma Planning
DRW Holdings
UBS Group
Hrt Financial
Annandale Capital
Cetera Investment Advisers
Two Sigma Securities
Morgan Stanley
Us Bancorp
Gleason Group
Newbridge Financial Services Group
TD Waterhouse Canada
Royal Bank of Canada
Advisor Group Holdings

View all funds holding Aptose Biosciences